Treatment of Infrapopliteal Arterial Occlusive Disease in Critical Limb Ischemia
- 14 November 2014
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 31 (04) , 370-374
Abstract
There is increasing evidence supporting endovascular intervention in patients with critical limb ischemia (CLI) and infrapopliteal artery occlusion where in-line flow to the foot can be reestablished. Patients with CLI due to infrapopliteal arterial occlusive disease are a high-risk group in which the current reported amputation and mortality rates at 1 year are 25% and 20 to 25%, respectively.[1] [2] Treatment of infrapopliteal arterial disease is vital to prevent amputation, relieve ischemic pain, heal lower extremity wounds, and prevent gangrene. Technical success rates are often high (approaching 90%) in infrapopliteal angioplasty, with associated clinical success of approximately 70% in some larger series of patients with CLI.[3] Predictors of a successful outcome include a short occlusion length and minimal vessels or stenoses needing treatment. The updated Trans-Atlantic Inter Society Consensus (TASC)–II guidelines concluded that there is increasing evidence to support the recommendation for angioplasty in patient with CLI and infrapopliteal artery occlusion; lesion length alone is no longer used to determine a recommendation for treatment (as was seen with the TASC-1 guidelines).[1] The following procedure describes our approach to treating infrapopliteal arterial occlusive disease.Keywords
This publication has 11 references indexed in Scilit:
- Percutaneous Transluminal Angioplasty versus Turbostatic Carbon–coated Stents in Infrapopliteal Arteries: InPeria II TrialRadiology, 2011
- Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemiaVasa, 2011
- First Experience With Drug-Eluting Balloons in Infrapopliteal ArteriesJACC, 2011
- Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trialEuropean Heart Journal, 2011
- Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-upJournal of Vascular Surgery, 2010
- Update on PADI trial: Percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemiaJournal of Vascular Surgery, 2009
- Infrapopliteal angioplasty for critical limb ischemia: Relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbsJournal of Vascular Surgery, 2008
- Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemiaJournal of Vascular Surgery, 2008
- ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)JACC, 2006
- Subintimal Arterial Flossing with Antegrade–Retrograde Intervention (SAFARI) for Subintimal Recanalization to Treat Chronic Critical Limb IschemiaJournal of Vascular and Interventional Radiology, 2005